The effect of COVID 19 vaccination on kidney recipients
The effect of COVID 19 vaccination on kidney recipients Background: Nearly one year from the onset of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, safe and effective vaccines began distribution around the world. This study aimed to assess the rate of COVID-19 disease among vaccinated kidney transplant patients and the types of symptoms found within them. As a sample size, 159 cadavers' kidney recipients received two doses of the Sinopharm SARS-CoV-2 vaccine. Results: The mean age of the vaccinated participants was 49.44
The effect of COVID 19 vaccination on kidney recipients
Latifi Marzieh, Pourhosein Elahe, Rahban Habib, Pourhosein Maryam, Jafarian Arefeh, Eskandarzadeh Elnaz, Dehghani Sanaz*
Abstract
Background: Nearly one year from the onset of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, safe and effective vaccines began distribution around the world. This study aimed to assess the rate of COVID-19 disease among vaccinated kidney transplant patients and the types of symptoms found within them.
Design: This cross-sectional study was performed at the transplant ward and Organ Procurement Unit of Sina Hospital, Tehran, Iran. As a sample size, 159 cadavers' kidney recipients received two doses of the Sinopharm SARS-CoV-2 vaccine. The required data were collected using a checklist via conducting a face-to-face interview.
Results: The mean age of the vaccinated participants was 49.44 ± 13.87 years old. There were 73 (45.91%) vaccinated cases of SARS-CoV-2 infection during the study period, 18 cases (12.6%) occurred among fully vaccinated individuals, and 53 cases (33.3%) were among individuals who had received only one dose of vaccine.
45% of the fully vaccinated patients (received 2 doses vaccine) contracted SARS-CoV-2 from their families; 35% were infected through participation in social events (35%).
There was a significant difference in disease severity levels between the fully vaccinated group and the one-dose vaccinated (p<0.023). The severe disease occurred in 2 patients after vaccination, who were subsequently admitted to the hospital.
There was a significant difference between the number of kidney transplant days and infection with SARS-CoV-2 before (P = 0.15) and after vaccination (p<0.015).
Conclusion: Even after vaccination, kidney recipients are still at the risk of contracting SARS-CoV-2. In addition to these results, the efficacy of vaccination in preventing death caused by SARS-CoV-2 was confirmed.
Keywords: SARS-CoV-2 vaccine, Kidney transplantation, Cadaveric donor
https://pubmed.ncbi.nlm.nih.gov/35777613/
ارسال نظر